Canaccord Genuity Maintains Buy on Compass Pathways, Lowers Price Target to $48
COMPASS Pathways plc +1.11% Pre
COMPASS Pathways plc CMPS | 7.30 7.30 | +1.11% 0.00% Pre |
Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:
CMPS) with a Buy and lowers the price target from $50 to $48.